Avidity Biosciences
RNAM
#1858
Rank
NZ$20.09 B
Marketcap
NZ$130.06
Share price
0.00%
Change (1 day)
45.33%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Last known market cap: NZ$20.09 Billion

As of November 2026 Avidity Biosciences has a market cap of NZ$20.09 Billion. This makes Avidity Biosciences the world's 1858th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026NZ$20.09 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$298.89 B 1,387.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$183.41 B 812.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$3.14 B-84.35%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$9.57 B-52.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.38 B-98.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.46 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$19.52 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$6.88 B-65.73%๐Ÿ‡บ๐Ÿ‡ธ USA